Management of chronic viral hepatitis B and D.
作者信息
Dietz-Fricke Christopher, Wedemeyer Heiner
机构信息
Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Excellence Cluster Resist, Hannover Medical School, Germany.
出版信息
Clin Liver Dis (Hoboken). 2024 Jun 12;23(1):e0221. doi: 10.1097/CLD.0000000000000221. eCollection 2024 Jan-Jun.
Abstract
摘要
相似文献
1
Management of chronic viral hepatitis B and D.
Clin Liver Dis (Hoboken). 2024 Jun 12;23(1):e0221. doi: 10.1097/CLD.0000000000000221. eCollection 2024 Jan-Jun.
2
Association between vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China.
J Gastroenterol Hepatol. 2015 Mar;30(3):566-74. doi: 10.1111/jgh.12783.
3
Review article: the management of hepatitis A, B, D and non-A non-B.
Aliment Pharmacol Ther. 1989 Feb;3(1):1-20. doi: 10.1111/j.1365-2036.1989.tb00186.x.
4
[Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region].
Vopr Virusol. 2021 Mar 7;66(1):74-83. doi: 10.36233/0507-4088-29.
5
Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
J Viral Hepat. 2018 Nov;25(11):1384-1394. doi: 10.1111/jvh.12947. Epub 2018 Jul 10.
6
Low vitamin D levels are associated with high viral loads in patients with chronic hepatitis B: a systematic review and meta-analysis.
BMC Gastroenterol. 2019 Jun 11;19(1):84. doi: 10.1186/s12876-019-1004-2.
7
New perspectives of biomarkers for the management of chronic hepatitis B.
Clin Mol Hepatol. 2016 Dec;22(4):423-431. doi: 10.3350/cmh.2016.0069. Epub 2016 Dec 25.
8
Targeting virus-specific CD8+ T cells for treatment of chronic viral hepatitis: from bench to bedside.
Expert Opin Biol Ther. 2024 Jan-Feb;24(1-2):77-89. doi: 10.1080/14712598.2024.2313112. Epub 2024 Feb 7.
9
Vitamin D serum level is associated with Child-Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients.
Medicine (Baltimore). 2016 Jul;95(27):e3926. doi: 10.1097/MD.0000000000003926.
本文引用的文献
1
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Hepatology. 2024 Sep 1;80(3):664-673. doi: 10.1097/HEP.0000000000000847. Epub 2024 Mar 13.
2
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection.
Aliment Pharmacol Ther. 2024 Mar;59(6):752-761. doi: 10.1111/apt.17878. Epub 2024 Jan 11.
3
EASL Clinical Practice Guidelines on hepatitis delta virus.
J Hepatol. 2023 Aug;79(2):433-460. doi: 10.1016/j.jhep.2023.05.001. Epub 2023 Jun 24.
4
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression.
JHEP Rep. 2023 Apr 7;5(8):100751. doi: 10.1016/j.jhepr.2023.100751. eCollection 2023 Aug.
5
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med. 2023 Jul 6;389(1):22-32. doi: 10.1056/NEJMoa2213429. Epub 2023 Jun 22.
6
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients.
JHEP Rep. 2023 Mar 15;5(4):100686. doi: 10.1016/j.jhepr.2023.100686. eCollection 2023 Apr.
7
Bulevirtide-based treatment strategies for chronic hepatitis delta: A review.
J Viral Hepat. 2023 Apr;30 Suppl 1:26-32. doi: 10.1111/jvh.13811. Epub 2023 Feb 27.
8
Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):796-829. doi: 10.1016/S2468-1253(22)00124-8. Epub 2022 Jun 21.
9
[Not Available].
Z Gastroenterol. 2021 Jul;59(7):691-776. doi: 10.1055/a-1498-2512. Epub 2021 Jul 12.
10
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
J Hepatol. 2020 Sep;73(3):523-532. doi: 10.1016/j.jhep.2020.04.008. Epub 2020 Apr 23.
Zotero 插件